150 related articles for article (PubMed ID: 15786961)
1. [Effect of cardiocyclide on the electrophysiological parameters of heart in experiments with vagus nerve excitation in narcotized dogs].
Kaverina NV; Lyskovets VV; Popova EV
Eksp Klin Farmakol; 2005; 68(1):30-5. PubMed ID: 15786961
[TBL] [Abstract][Full Text] [Related]
2. [A comparative study of the effects of antiarrhythmic class III drugs cardiocyclide and sotalol on the atrioventricular fibrillation caused by vagus nerve excitation in narcotized dogs].
Popova EP
Eksp Klin Farmakol; 2005; 68(4):28-32. PubMed ID: 16193653
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of the electrophysiological properties of class iii medicinals (cardiocyclide, nibentan, sotalol) and evaluation of their efficacy in atrial fibrillation produced by auricular and vagal stimulation].
Kaverina NV; Lyskovtsev VV; Popova EP
Eksp Klin Farmakol; 2007; 70(1):11-6. PubMed ID: 17402585
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacology of antiarrhythmia agents: the new aspects].
Kaverina NV; Chichkanov GG
Eksp Klin Farmakol; 2003; 66(2):46-52. PubMed ID: 12962048
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition by a class III antiarrhythmic agent, E-4031, of the negative chronotropic response to parasympathetic stimulation in anesthetized dogs.
Imamura H; Furukawa Y; Nakano H; Kasama M; Hoyano Y; Chiba S
J Pharmacol Exp Ther; 1996 Feb; 276(2):467-72. PubMed ID: 8632311
[TBL] [Abstract][Full Text] [Related]
6. Antifibrillatory properties of mivacurium in a canine model of atrial fibrillation.
Patterson E; Lu Z; Lin J; Scherlag BJ; Po SS; Coscia D; Lazzara R
J Cardiovasc Pharmacol; 2008 Mar; 51(3):293-303. PubMed ID: 18356695
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study of electrophysiological mechanisms of anti-arrhythmia III class agents, cardiocyclide, nibentan, and sotalol during experimental myocardial infarction and sympathetic stimulation].
Kaverina NV; Lyskovtsev VV; Popova EP
Eksp Klin Farmakol; 2003; 66(1):27-33. PubMed ID: 12683077
[TBL] [Abstract][Full Text] [Related]
8. Antifibrillatory actions of cisatracurium: an atrial specific M2 receptor antagonist.
Patterson E; Scherlag BJ; Zhou J; Jackman WM; Lazzara R; Coscia D; Po S
J Cardiovasc Electrophysiol; 2008 Aug; 19(8):861-8. PubMed ID: 18363689
[TBL] [Abstract][Full Text] [Related]
9. [The structural dynamics of vagus influence on the heart rhythm in exposures directed at altering the acting acetylcholine concentration].
Pokrovskiĭ VM; Osadchiĭ OE
Biull Eksp Biol Med; 1992 Dec; 114(12):570-3. PubMed ID: 1292673
[TBL] [Abstract][Full Text] [Related]
10. [Effect of the novel III class anti-arrhythmia preparation (AL-275) in experimental myocardium and sympathetic stimulation].
Kaverina NV; Lyskovtsev VV; Kishchuk EP
Eksp Klin Farmakol; 2001; 64(1):33-7. PubMed ID: 11544801
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute vagal nerve stimulation on the early passive electrical changes induced by myocardial ischaemia in dogs: heart rate-mediated attenuation.
Del Rio CL; Dawson TA; Clymer BD; Paterson DJ; Billman GE
Exp Physiol; 2008 Aug; 93(8):931-44. PubMed ID: 18376003
[TBL] [Abstract][Full Text] [Related]
12. [Effect of the preparations amiodarone, pexid and CERM-1978 on sinus rhythm and atrioventricular conduction in unanesthetized dogs].
Georgiev G
Eksp Med Morfol; 1977; 16(4):202-7. PubMed ID: 590177
[TBL] [Abstract][Full Text] [Related]
13. [The action of met-enkephalin on sinus arrhythmia during the burst stimulation of the vagus nerve].
Osadchiĭ OE; Pokrovskiĭ VM; Cherednik IL; Kurzanov AN
Biull Eksp Biol Med; 1993 Jul; 116(7):4-6. PubMed ID: 8400175
[TBL] [Abstract][Full Text] [Related]
14. Selective suppression of neural excitation by tetrodotoxin injected into the canine atrioventricular node artery.
Iijima T; Motomura S; Taira N; Hashimoto K
J Pharmacol Exp Ther; 1974 Jun; 189(3):638-45. PubMed ID: 4843165
[No Abstract] [Full Text] [Related]
15. Peripheral inhibition of the parasympathetic nervous system by angiotensin.
Potter EK
Clin Exp Pharmacol Physiol Suppl; 1982; 7():51-5. PubMed ID: 6958401
[TBL] [Abstract][Full Text] [Related]
16. [Effect of the class III antiarrhythmic drug nibentan in vagotonic atrial fibrillation].
Popova EP; Lyskovtsev VV; Kaverina NV
Eksp Klin Farmakol; 2006; 69(1):24-7. PubMed ID: 16579055
[TBL] [Abstract][Full Text] [Related]
17. [The effect of novel class III anti-arrhythmia agents cardiocyclide and nibentan during activation of cardiac beta-adrenoreceptors].
Turilova AI; Katsitadze NSh; Kaverina NV
Eksp Klin Farmakol; 2002; 65(5):29-30. PubMed ID: 12596510
[TBL] [Abstract][Full Text] [Related]
18. [Tonus of the sympathetic nervous system].
Smirnov VM
Biull Eksp Biol Med; 1993 May; 115(5):451-3. PubMed ID: 8043816
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of cervical vagosympathetic and mediastinal nerve activation on atrial arrhythmia formation in dogs.
Pagé P; Andrew Armour J; Yin Y; Vermeulen M; Nadeau R; Cardinal R
Auton Neurosci; 2006 Jul; 128(1-2):9-18. PubMed ID: 16466969
[TBL] [Abstract][Full Text] [Related]
20. Cervical vagosympathetic and mediastinal nerves activation effects on atrial arrhythmia formation.
Nadeau R; Cardinal R; Armour JA; Kus T; Richer LP; Vermeulen M; Yin Y; Pagé P
Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():34-6. PubMed ID: 17584676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
